Patents by Inventor Robert Felix Galyean

Robert Felix Galyean has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • V1a receptor agonists
    Patent number: 9644000
    Abstract: Compounds of formula (I), salts thereof, and compositions and uses thereof are described. The compounds are useful as V1a vasopressin agonists, for the treatment of, e.g., complications of cirrhosis, including bacterial peritonitis, HRS2 and refractory ascites.
    Type: Grant
    Filed: May 9, 2013
    Date of Patent: May 9, 2017
    Assignee: Ferring B.V.
    Inventors: Kazimierz Wisniewski, Geoffrey S. Harris, Robert Felix Galyean
  • V1a Receptor Agonists
    Publication number: 20150126432
    Abstract: Compounds of formula (I), salts thereof, and compositions and uses thereof are described. The compounds are useful as V1a vasopressin agonists, for the treatment of e.g., complications of cirrhosis, including bacterial peritonitis, HRS2 and refractory ascites.
    Type: Application
    Filed: May 9, 2013
    Publication date: May 7, 2015
    Inventors: Kazimierz Wisniewski, Geoffrey S. Harris, Robert Felix Galyean
  • Compounds
    Patent number: 8883965
    Abstract: The present invention relates to novel compounds, pharmaceutical compositions comprising the same, use of said compounds for the manufacture of a medicament for treatment of inter alia shock conditions as well as to a method for treatment of said conditions, wherein said compounds are administered. The compounds are represented by the general formula (I), as further defined in the specification.
    Type: Grant
    Filed: February 5, 2007
    Date of Patent: November 11, 2014
    Assignee: Ferring B.V.
    Inventors: Kazimierz Wisniewski, Robert Felix Galyean
  • Peptidic vasopressin receptor agonists
    Patent number: 8778881
    Abstract: The present application relates to novel compounds, pharmaceutical compositions comprising the same, use of said compounds for the manufacture of a medicament for treatment of inter alia shock conditions as well as to a method for treatment of said conditions, wherein said compounds are administered. The compounds are represented by the general formula (I), as further defined in the specification.
    Type: Grant
    Filed: March 1, 2012
    Date of Patent: July 15, 2014
    Assignee: Ferring B.V.
    Inventors: Kazimierz Wisniewski, Claudio Schteingart, Regent LaPorte, Robert Felix Galyean, Pierre J.M. Riviere
  • Peptidic Vasopressin Receptor Agonists
    Publication number: 20120196808
    Abstract: The present application relates to novel compounds, pharmaceutical compositions comprising the same, use of said compounds for the manufacture of a medicament for treatment of inter alia shock conditions as well as to a method for treatment of said conditions, wherein said compounds are administered. The compounds are represented by the general formula (I), as further defined in the specification.
    Type: Application
    Filed: March 1, 2012
    Publication date: August 2, 2012
    Applicant: FERRING B.V.
    Inventors: Kazimierz Wisniewski, Claudio Schteingart, Regent LaPorte, Robert Felix Galyean, Pierre Riviere
  • Peptidic vasopressin receptor agonists
    Patent number: 8148319
    Abstract: The present invention relates to novel compounds, pharmaceutical compositions comprising the same, use of said compounds for the manufacture of a medicament for treatment of inter alia shock conditions as well as to a method for treatment of said conditions, wherein said compounds are administered. The compounds are represented by the general formula (I), as further defined in the specification.
    Type: Grant
    Filed: August 3, 2005
    Date of Patent: April 3, 2012
    Assignee: Ferring B.V.
    Inventors: Kazimierz Wisniewski, Claudio Schteingart, Regent Laporte, Robert Felix Galyean, Pierre Riviere
  • Novel Compounds
    Publication number: 20090275522
    Abstract: The present invention relates to novel compounds, pharmaceutical compositions comprising the same, use of said compounds for the manufacture of a medicament for treatment of inter alia shock conditions as well as to a method for treatment of said conditions, wherein said compounds are administered. The compounds are represented by the general formula (I), as further defined in the specification.
    Type: Application
    Filed: February 5, 2007
    Publication date: November 5, 2009
    Applicant: FERRING B.V.
    Inventors: Kazimierz A. Wisniewski, Robert Felix Galyean
  • Peptidic vasopressin receptor agonists
    Publication number: 20090054309
    Abstract: The present invention relates to novel compounds, pharmaceutical compositions comprising the same, use of said compounds for the manufacture of a medicament for treatment of inter alia shock conditions as well as to a method for treatment of said conditions, wherein said compounds are administered. The compounds are represented by the general formula (I), as further defined in the specification.
    Type: Application
    Filed: August 3, 2005
    Publication date: February 26, 2009
    Applicant: Ferring B.V.
    Inventors: Kazimierz Wisniewski, Claudio Schteingart, Regent Laporte, Robert Felix Galyean, Pierre Riviere